RBC
CELG

Ronald Blue & Co’s Celgene Corp CELG Stock Holding History

Ronald Blue & Co’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,267
Closed -$272K – 229
2015
Q4 		$272K Sell
2,267
-6,601
-74% -$764K 0.01% 137
2015
Q3 		$959K Sell
8,868
-340
-4% -$42.2K 0.05% 80
2015
Q2 		$1.07M Buy
9,208
+568
+7% +$64.9K 0.05% 79
2015
Q1 		$996K Sell
8,640
-451
-5% -$53.9K 0.05% 90
2014
Q4 		$1.02M Buy
9,091
+557
+7% +$58.7K 0.05% 87
2014
Q3 		$809K Buy
8,534
+68
+0.8% +$6.14K 0.05% 99
2014
Q2 		$727K Buy
8,466
+620
+8% +$47.1K 0.05% 121
2014
Q1 		$548K Sell
7,846
-158
-2% -$12.5K 0.04% 148
2013
Q4 		$676K Buy
8,004
+1,570
+24% +$124K 0.05% 110
2013
Q3 		$496K Buy
6,434
+446
+7% +$31.3K 0.04% 128
2013
Q2 		$350K Buy
+5,988
New +$360K 0.03% 85

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Ronald Blue & Co's CELG Position: Q1 2016 in Review

Ronald Blue & Co sold out of Celgene Corp (CELG) in Q1 2016, closing a stake of 2,267 shares — an estimated $272K sold.

Ronald Blue & Co first reported a position in CELG in Q2 2013 and held it in 11 quarters. The position peaked at $1.07M in Q2 2015. 1,224 funds tracked by Wall St. Rank hold CELG as of Q1 2016.

  • Ronald Blue & Co reported no remaining Celgene Corp position as of Q1 2016 after selling out during the quarter.
  • Ronald Blue & Co sold 2,267 Celgene Corp shares in Q1 2016, an estimated $272K.
  • Ronald Blue & Co first reported a position in Celgene Corp in Q2 2013 and held it in 11 quarters.
  • Ronald Blue & Co's Celgene Corp position peaked at $1.07M in Q2 2015.
  • 1,224 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2016.

Based on Ronald Blue & Co's 13F filing for Q1 2016, filed 13 May 2016.